Cargando…

Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review

OBJECTIVE: Although Markov cohort models represent one of the most common forms of decision-analytic models used in health care decision-making, correct implementation of such models requires reliable estimation of transition probabilities. This study sought to identify consensus statements or guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Olariu, Elena, Cadwell, Kevin K, Hancock, Elizabeth, Trueman, David, Chevrou-Severac, Helene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589111/
https://www.ncbi.nlm.nih.gov/pubmed/28979151
http://dx.doi.org/10.2147/CEOR.S135445
_version_ 1783262278320128000
author Olariu, Elena
Cadwell, Kevin K
Hancock, Elizabeth
Trueman, David
Chevrou-Severac, Helene
author_facet Olariu, Elena
Cadwell, Kevin K
Hancock, Elizabeth
Trueman, David
Chevrou-Severac, Helene
author_sort Olariu, Elena
collection PubMed
description OBJECTIVE: Although Markov cohort models represent one of the most common forms of decision-analytic models used in health care decision-making, correct implementation of such models requires reliable estimation of transition probabilities. This study sought to identify consensus statements or guidelines that detail how such transition probability matrices should be estimated. METHODS: A literature review was performed to identify relevant publications in the following databases: Medline, Embase, the Cochrane Library, and PubMed. Electronic searches were supplemented by manual-searches of health technology assessment (HTA) websites in Australia, Belgium, Canada, France, Germany, Ireland, Norway, Portugal, Sweden, and the UK. One reviewer assessed studies for eligibility. RESULTS: Of the 1,931 citations identified in the electronic searches, no studies met the inclusion criteria for full-text review, and no guidelines on transition probabilities in Markov models were identified. Manual-searching of the websites of HTA agencies identified ten guidelines on economic evaluations (Australia, Belgium, Canada, France, Germany, Ireland, Norway, Portugal, Sweden, and UK). All identified guidelines provided general guidance on how to develop economic models, but none provided guidance on the calculation of transition probabilities. One relevant publication was identified following review of the reference lists of HTA agency guidelines: the International Society for Pharmacoeconomics and Outcomes Research taskforce guidance. This provided limited guidance on the use of rates and probabilities. CONCLUSIONS: There is limited formal guidance available on the estimation of transition probabilities for use in decision-analytic models. Given the increasing importance of cost-effectiveness analysis in the decision-making processes of HTA bodies and other medical decision-makers, there is a need for additional guidance to inform a more consistent approach to decision-analytic modeling. Further research should be done to develop more detailed guidelines on the estimation of transition probabilities.
format Online
Article
Text
id pubmed-5589111
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55891112017-10-04 Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review Olariu, Elena Cadwell, Kevin K Hancock, Elizabeth Trueman, David Chevrou-Severac, Helene Clinicoecon Outcomes Res Review OBJECTIVE: Although Markov cohort models represent one of the most common forms of decision-analytic models used in health care decision-making, correct implementation of such models requires reliable estimation of transition probabilities. This study sought to identify consensus statements or guidelines that detail how such transition probability matrices should be estimated. METHODS: A literature review was performed to identify relevant publications in the following databases: Medline, Embase, the Cochrane Library, and PubMed. Electronic searches were supplemented by manual-searches of health technology assessment (HTA) websites in Australia, Belgium, Canada, France, Germany, Ireland, Norway, Portugal, Sweden, and the UK. One reviewer assessed studies for eligibility. RESULTS: Of the 1,931 citations identified in the electronic searches, no studies met the inclusion criteria for full-text review, and no guidelines on transition probabilities in Markov models were identified. Manual-searching of the websites of HTA agencies identified ten guidelines on economic evaluations (Australia, Belgium, Canada, France, Germany, Ireland, Norway, Portugal, Sweden, and UK). All identified guidelines provided general guidance on how to develop economic models, but none provided guidance on the calculation of transition probabilities. One relevant publication was identified following review of the reference lists of HTA agency guidelines: the International Society for Pharmacoeconomics and Outcomes Research taskforce guidance. This provided limited guidance on the use of rates and probabilities. CONCLUSIONS: There is limited formal guidance available on the estimation of transition probabilities for use in decision-analytic models. Given the increasing importance of cost-effectiveness analysis in the decision-making processes of HTA bodies and other medical decision-makers, there is a need for additional guidance to inform a more consistent approach to decision-analytic modeling. Further research should be done to develop more detailed guidelines on the estimation of transition probabilities. Dove Medical Press 2017-09-01 /pmc/articles/PMC5589111/ /pubmed/28979151 http://dx.doi.org/10.2147/CEOR.S135445 Text en © 2017 Olariu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Olariu, Elena
Cadwell, Kevin K
Hancock, Elizabeth
Trueman, David
Chevrou-Severac, Helene
Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review
title Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review
title_full Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review
title_fullStr Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review
title_full_unstemmed Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review
title_short Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review
title_sort current recommendations on the estimation of transition probabilities in markov cohort models for use in health care decision-making: a targeted literature review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589111/
https://www.ncbi.nlm.nih.gov/pubmed/28979151
http://dx.doi.org/10.2147/CEOR.S135445
work_keys_str_mv AT olariuelena currentrecommendationsontheestimationoftransitionprobabilitiesinmarkovcohortmodelsforuseinhealthcaredecisionmakingatargetedliteraturereview
AT cadwellkevink currentrecommendationsontheestimationoftransitionprobabilitiesinmarkovcohortmodelsforuseinhealthcaredecisionmakingatargetedliteraturereview
AT hancockelizabeth currentrecommendationsontheestimationoftransitionprobabilitiesinmarkovcohortmodelsforuseinhealthcaredecisionmakingatargetedliteraturereview
AT truemandavid currentrecommendationsontheestimationoftransitionprobabilitiesinmarkovcohortmodelsforuseinhealthcaredecisionmakingatargetedliteraturereview
AT chevrouseverachelene currentrecommendationsontheestimationoftransitionprobabilitiesinmarkovcohortmodelsforuseinhealthcaredecisionmakingatargetedliteraturereview